José Mauricio Mota

5PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 30, 2025
Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources.

Diana Del Cisne Pineda, Gabriel Berlingieri Polho, Yumi Ricucci Shinkado

|Jul 14, 2023
Neurovascular and hemodynamic responses to mental stress and exercise in severe COVID-19 survivors.

Diego Faria, Renata Moll-Bernardes, Laura Testa

|Apr 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.

Isabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida

|Sep 09, 2022
PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling.

Carlos Wagner S Wanderley, Alexandre G M Maganin, Beatriz Adjafre

|May 01, 2019
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials.

Jose Mauricio Mota, Andrew J Armstrong, Steven M Larson

Pageof 1